Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus

Asia Pacific Journal of Clinical Nutrition

Volumn 20, Issue 4, 2011, Pages 593-602

  Yang, Bin ^a   Chen, Ying ^a   Xu, Tongchen ^a,b   Yu, Yinghua ^a,c   Huang, Tao ^a   Hu, Xiaojie ^a   Li, Duo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANDONG PEANUT RESEARCH INSTITUTE   (China)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Fasting glucose; Lipids; Meta analysis; Soy products; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD; DIET; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HUMANS; MALE; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 84863344309     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157-77.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
3. Krook A, Holm I, Pettersson S, Wallberg-Henriksson H. Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Physiol Funct Imaging. 2003;23:21-30.
4. Cater NB, Garg A. The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus. Curr Diab Rep. 2002;2:289-94.
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
6. Lavigne C, Marette A, Jacques H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab. 2000; 278:E491-500.
7. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr. 2004;134:522-9.
8. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006;79: 1578-84.
9. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr. 1998;128:209-13.
10. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005;81:397-408.
11. Anderson JW, Johnstone BM, Cook-Newell ME. Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-82.
12. Lopes GKB, Schulman HM, Hermes-Lima M. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. BBA-Gen Subjects. 1999;1472:142-52.
13. Feskens EJ, Virtanen SM, Rasanen L, Tuomilehto J, Stengard J, Pekkanen J et al. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care. 1995;18:1104-12.
14. Villegas R, Gao YT, Yang G, Li HL, Elasy TA, Zheng W et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008;87:162-7.
15. Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M et al. Soy Product and Isoflavone Intakes Are Associated with a Lower Risk of Type 2 Diabetes in Overweight Japanese Women. J of Nutr. 2010;140:580-6.
16. Morimoto Y, Steinbrecher A, Kolonel L, Maskarinec G. Soy consumption is not protective against diabetes in Hawaii: the Multiethnic Cohort. Eur J Clin Nutr. 2010;65:279-82.
17. Ho SC, Chen YM, Ho SS, Woo JL. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause. 2007;14: 905-12.
18. Shahbazian H, Reza A, Javad S, Heshmatollah S, Mahmood L, Ali A et al. Beneficial effects of soy protein isoflavones on lipid and blood glucose concentrations in type 2 diabetic subjects. Saudi Med J. 2007;28:652-4.
19. Higgins J GS. Cochrane handbook for systematic reviews of interventions 4.2.6. UK: John Wiley & Sons, Ltd, Chichester; 2006.
20. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769-73.
21. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr. 1998;68:1347S-53.
22. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001;24:228-33.
23. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002;25:1709-14.
24. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr. 2003;57:1292-4.
25. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004;134:1874-80.
26. Gonzalez S, Jayagopal V, Kilpatrick ES, Chapman T, Atkin SL. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2007;30:1871-3.
27. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31:648-54.
28. Gobert CP, Pipe EA, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soya protein does not affect glycaemic control in adults with type 2 diabetes. Br J Nutr. 2009;103:412-21.
29. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr. 2009;139:1700-6.
30. Ble-Castillo JL, Aparicio-Trapala MA, Francisco-Luria MU, Cordova-Uscanga R, Rodriguez-Hernandez A, Mendez JD et al. Effects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabetics. Int J Environ Res Public Health. 2010;7:1953-62.
31. Program LMCotLRC. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem. 1977;23:60-3.
32. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002; 76:1191-201.
33. Gobert CP, Duncan AM. Consumption, perceptions and knowledge of soy among adults with type 2 diabetes. J Am Coll Nutr. 2009;28:203-18.
34. Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr. 2003;133:2874-8.
35. Liang W, Lee AH, Binns CW, Huang R, Hu D, Shao H. Soy consumption reduces risk of ischemic stroke: a case-control study in southern china. Neuroepidemiology. 2009;33:111-6.
36. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44: 720-32.
37. Neeli H, Gadi R, Rader DJ. Managing diabetic dyslipidemia: beyond statin therapy. Curr Diab Rep. 2009;9:11-7.
38. Eastman RC, Keen H. The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet. 1997;350(S1):SI29-32.
39. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148-56.
40. Mullen E, Brown RM, Osborne TF, Shay NF. Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells. J Nutr. 2004;134:2942-7.
41. Mezei O, Li Y, Mullen E, Ross-Viola JS, Shay NF. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms. Physiol Genomics. 2006;26:8-14.
42. Orgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood). 2008;233:1066-80.
43. Cheng SY, Shaw NS, Tsai KS, Chen CY. The hypoglycemic effects of soy isoflavones on postmenopausal women. J Womens Health (Larchmt). 2004;13:1080-6.
44. Hamilton-Reeves J, Vazquez G, Duval S, Phipps W, Kurzer M, Messina M. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil Steril. 2010;94:997-1007.
45. Hooper L, Ryder J, Kurzer M, Lampe J, Messina M, Phipps W et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update. 2009;15:423-40.
46. Ding E, Song Y, Malik V, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288.
47. Goodman-Gruen D, Barrett-Connor E. Sex hormonebinding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care. 1997; 20:645-9.
48. Association AD. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(S1):S11-61.
49. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterollowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.